Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion

The American Journal of Cardiology
Chung-Wah SiuHung-Fat Tse

Abstract

The aim of this study was to investigate the effect of statin therapy on arrhythmia recurrence in patients with lone atrial fibrillation (AF). From July 1998 to December 1999, 62 patients with lone persistent AF lasting >/=3 months underwent successful external cardioversion. After a mean follow-up of 44 months, 85% had recurrence of AF. The use of statins was associated with a significant decrease in the risk of arrhythmia recurrence after successful cardioversion of AF. The result of this retrospective study demonstrates that the use of statins in patients with lone AF was associated with a significant decrease in the risk of arrhythmia recurrence after successful cardioversion.

References

Jan 19, 2007·Current Atherosclerosis Reports·Dominique BeaudryRobert Chilton
Jul 17, 2008·Herzschrittmachertherapie & Elektrophysiologie·Anil-Martin SinhaMartin Schmidt
Sep 24, 2005·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Akiko Shiroshita-TakeshitaStanley Nattel
Mar 5, 2008·Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing·Maya GuglinAnne B Curtis
Mar 30, 2010·General Thoracic and Cardiovascular Surgery·Kiyoshi TamuraNaoto Miyagi
Sep 24, 2008·Archives of Cardiovascular Diseases·Stephane Hatem, Franck Boccara
Oct 8, 2005·American Heart Journal·Ratika ParkashWilliam G Stevenson
Apr 13, 2005·Medical Hypotheses·Tong Liu, Guangping Li
Dec 21, 2007·Nature Clinical Practice. Cardiovascular Medicine·Irina Savelieva, John Camm
Aug 29, 2012·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Jing LiMin Pan
Sep 1, 2009·European Heart Journal·Aldo P MaggioniGISSI-HF Investigators
Jan 13, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Dimpi PatelA Natale
Mar 2, 2010·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Pasquale SantangeliA Natale
Apr 26, 2011·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Irene SavelievaA John Camm
Dec 21, 2011·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Boon-Hor ChongChung-Wah Siu
Jun 20, 2008·Cardiology in Review·Justin M BachmannJoseph E Marine
Jul 21, 2010·International Journal of Clinical Practice·A AryaA N Sulke
Feb 5, 2005·Pathophysiology of Haemostasis and Thrombosis·Anirban Choudhury, Gregory Y H Lip
Jul 16, 2011·Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre·Kenan DemirBulent Behlul Altunkeser
May 28, 2010·Circulation. Arrhythmia and Electrophysiology·Omar BatalMina K Chung
Mar 25, 2005·Journal of Negative Results in Biomedicine·Nusrat ShafiqAnil Grover
Dec 17, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi YamashitaTadanori Aizawa
Sep 8, 2011·Environmental Health Perspectives·Andrew J GhioMartha Sue Carraway
Apr 16, 2009·International Heart Journal·Yoshiyuki HirayamaKyoichi Mizuno
May 11, 2011·International Journal of General Medicine·Christos G Mihos, Orlando Santana
Jul 11, 2009·Vascular Health and Risk Management·Hadi Ar HadiSamer Ellahham
Nov 26, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Abhimanyu BeriSnigdha B Mahajan
Jun 9, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Concepción MoroRoberto Matía
Dec 18, 2009·Future Cardiology·Khaja S MohammedSimone Musco
Sep 1, 2006·Future Cardiology·Simone MuscoPeter R Kowey
Aug 8, 2013·Antioxidants & Redox Signaling·Oliver Adam, Ulrich Laufs

Citations

Jan 19, 2000·Circulation·D J MaronM F Linton
Dec 6, 2002·The New England Journal of Medicine·D George WyseAtrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderRate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Apr 2, 2003·Circulation·Hani SinnoStanley Nattel

Related Concepts

Lone Atrial Fibrillation
Recurrent Malignant Neoplasm
Atrial Fibrillation
Hypolipidemic Agents
Cardiac Depressants
Antilipemic agent
Recurrence (Disease Attribute)
Electroversion Therapy
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Cox Proportional Hazards Models

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.